Skip to main content

Prediction and prevention of chemotherapy-induced cardiomyopathy: can it be done?

Publication ,  Journal Article
Granger, CB
Published in: Circulation
December 5, 2006

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

December 5, 2006

Volume

114

Issue

23

Start / End Page

2432 / 2433

Location

United States

Related Subject Headings

  • Stroke Volume
  • Risk Factors
  • Razoxane
  • Predictive Value of Tests
  • Humans
  • Heart
  • Dose-Response Relationship, Drug
  • Cardiovascular System & Hematology
  • Cardiovascular Agents
  • Cardiomyopathies
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Granger, C. B. (2006). Prediction and prevention of chemotherapy-induced cardiomyopathy: can it be done? Circulation, 114(23), 2432–2433. https://doi.org/10.1161/CIRCULATIONAHA.106.666248
Granger, Christopher B. “Prediction and prevention of chemotherapy-induced cardiomyopathy: can it be done?Circulation 114, no. 23 (December 5, 2006): 2432–33. https://doi.org/10.1161/CIRCULATIONAHA.106.666248.
Granger CB. Prediction and prevention of chemotherapy-induced cardiomyopathy: can it be done? Circulation. 2006 Dec 5;114(23):2432–3.
Granger, Christopher B. “Prediction and prevention of chemotherapy-induced cardiomyopathy: can it be done?Circulation, vol. 114, no. 23, Dec. 2006, pp. 2432–33. Pubmed, doi:10.1161/CIRCULATIONAHA.106.666248.
Granger CB. Prediction and prevention of chemotherapy-induced cardiomyopathy: can it be done? Circulation. 2006 Dec 5;114(23):2432–2433.

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

December 5, 2006

Volume

114

Issue

23

Start / End Page

2432 / 2433

Location

United States

Related Subject Headings

  • Stroke Volume
  • Risk Factors
  • Razoxane
  • Predictive Value of Tests
  • Humans
  • Heart
  • Dose-Response Relationship, Drug
  • Cardiovascular System & Hematology
  • Cardiovascular Agents
  • Cardiomyopathies